Titan Medical Inc. Ordinary Shares
TMDI
TMDI was delisted on the 9th of March, 2023.
45 hedge funds and large institutions have $1.03M invested in Titan Medical Inc. Ordinary Shares in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 6 closing their positions.
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
7% more funds holding
Funds holding: 42 → 45 (+3)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
53% less capital invested
Capital invested by funds: $2.18M → $1.03M (-$1.15M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$58.3K |
| 2 |
Renaissance Technologies
New York
|
+$54.3K |
| 3 |
Two Sigma Advisers
New York
|
+$30.6K |
| 4 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
+$27.1K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$17.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$81K |
| 2 |
Morgan Stanley
New York
|
-$59.9K |
| 3 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
-$44.6K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$44K |
| 5 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$30.7K |
TMDI Hedge Fund Activity: Q4 2019 in Review
45 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Titan Medical Inc. Ordinary Shares (TMDI) for Q4 2019, worth a combined $1.03M — down 53% from $2.18M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new TMDI positions and 6 closed out — a net gain of 4 holders — while 7 added to existing stakes and 8 trimmed.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $58.3K. The largest seller was Citadel Advisors, exiting entirely with an estimated $81K sold.
- 45 institutional investors held Titan Medical Inc. Ordinary Shares (TMDI) as of Q4 2019, up from 42 in Q3 2019.
- Funds reported $1.03M of Titan Medical Inc. Ordinary Shares stock for Q4 2019, down 53% quarter-over-quarter.
- 10 funds opened new Titan Medical Inc. Ordinary Shares positions in Q4 2019 and 6 closed out, a net change of +4 holders.
- The largest Titan Medical Inc. Ordinary Shares buyer in Q4 2019 was JP Morgan Chase, an estimated $58.3K added.
- The largest Titan Medical Inc. Ordinary Shares seller in Q4 2019 was Citadel Advisors, an estimated $81K sold.
Based on aggregated 13F filings for Q4 2019.